Invention Grant
- Patent Title: RAD51 inhibitors and uses thereof
-
Application No.: US15554829Application Date: 2016-03-01
-
Publication No.: US10421753B2Publication Date: 2019-09-24
- Inventor: Jiewen Zhu , Wen-Hwa Lee , Hongyuan Chen , Xuning Guo , Xiao-Long Qiu
- Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Applicant Address: US CA Oakland
- Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Oakland
- Agency: Riverside Law LLP
- International Application: PCT/US2016/020269 WO 20160301
- International Announcement: WO2016/140971 WO 20160909
- Main IPC: C07D417/04
- IPC: C07D417/04 ; C07D401/04 ; C07D403/04 ; C07D209/44 ; C07D223/16 ; C07D471/04 ; C07D277/56
Abstract:
The present invention includes novel RAD51 inhibitors. The compounds of the invention may be useful in preventing or treating cancer in a subject in need thereof. The present invention also includes methods of preventing or treating cancer in a subject in need thereof by administering to the subject a therapeutically effective amount of a compound of the invention.
Public/Granted literature
- US20180057483A1 Novel RAD51 Inhibitors and Uses Thereof Public/Granted day:2018-03-01
Information query
